L. reuteri Protectis reduces pain in children with functional abdominal pain
In a newly published systematic review and meta-analysis L.reuteri Protectis (DSM 17938) was the only probiotic showing reduced...
Read moreBioGaia’s Board makes decision regarding extra dividend
In light of the continued uncertainty in connection to the global spread of Covid-19, BioGaia's Board of Directors...
Read moreInterim Report January – June 2020
Second quarter 2020 · Net sales amounted to SEK 244.7 million (222.3), an increase of 10% (excluding foreign exchange...
Read moreToo little focus on prevention in research on antibiotic resistance
A review based on publications addressing antibiotic resistance during the last 20 years shows that of 430,000 scientific articles...
Read moreBioGaia’s website now also in Spanish
Spanish is the third most spoken language in the world with more than 500 million, primarily in Spain, Latin America...
Read moreSuccessful first Brilliant Minds Studio Webinar
BioGaia’s very first virtual scientific webinar was broadcasted this week to a large number of healthcare professionals attending...
Read moreBioGaia appointed best company in Sweden
The Swiss investment management company Hérens Quality Asset Management has appointed BioGaia winner of Corporate Excellence Award 2019 Sweden....
Read moreGuidelines on role of probiotics in GI disorders
American Gastroenterology Association (AGA) has published Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders...
Read moreHBW Insight interview with Isabelle Ducellier
HBW Insight (Health Beauty Wellness Insight) has published an interview with BioGaia’s CEO, Isabelle Ducellier. Isabelle explains BioGaia&#...
Read more